Skip to Content
MilliporeSigma

Continuous API-crystal coating via coacervation in a tubular reactor.

International journal of pharmaceutics (2014-08-12)
M O Besenhard, A Thurnberger, R Hohl, E Faulhammer, J Rattenberger, J G Khinast
ABSTRACT

We present a proof-of-concept study of a continuous coating process of single API crystals in a tubular reactor using coacervation as a microencapsulation technique. Continuous API crystal coating can have several advantages, as in a single step (following crystallization) individual crystals can be prepared with a functional coating, either to change the release behavior, to protect the API from gastric juice or to modify the surface energetics of the API (i.e., to tailor the hydrophobic/hydrophilic characteristics, flowability or agglomeration tendency, etc.). The coating process was developed for the microencapsulation of a lipophilic core material (ibuprofen crystals of 20 μm- to 100 μm-size), with either hypromellose phthalate (HPMCP) or Eudragit L100-55. The core material was suspended in an aqueous solution containing one of these enteric polymers, fed into the tubing and mixed continuously with a sodium sulfate solution as an antisolvent to induce coacervation. A subsequent temperature treatment was applied to optimize the microencapsulation of crystals via the polymer-rich coacervate phase. Cross-linking of the coating shell was achieved by mixing the processed material with an acidic solution (pH<3). Flow rates, temperature profiles and polymer-to-antisolvent ratios had to be tightly controlled to avoid excessive aggregation, leading to pipe plugging. This work demonstrates the potential of a tubular reactor design for continuous coating applications and is the basis for future work, combining continuous crystallization and coating.

MATERIALS
Product Number
Brand
Product Description

Supelco
Ibuprofen
Sigma-Aldrich
Hydrochloric acid solution, 1 M
Sigma-Aldrich
Hydrochloric acid solution, 0.5 M
Sigma-Aldrich
Ethanol, 94.8-95.8%
Sigma-Aldrich
Acetic acid, SAJ first grade, ≥99.0%
Sigma-Aldrich
Hydrochloric acid solution, 0.2 M
Sigma-Aldrich
Acetic acid, ≥99.7%
Sigma-Aldrich
Hydrochloric acid solution, 2 M
Sigma-Aldrich
Acetic acid, ≥99.7%
Sigma-Aldrich
Hydrochloric acid, JIS special grade, 35.0-37.0%
Sigma-Aldrich
Hydrochloric acid, SAJ first grade, 35.0-37.0%
Sigma-Aldrich
Hydrogen chloride solution, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
Hydrochloric acid solution, 0.01 M
Sigma-Aldrich
Acetic acid, JIS special grade, ≥99.7%
Sigma-Aldrich
Hydrochloric acid solution, 6 M
Sigma-Aldrich
Acetic acid solution, 1 N, 1 M
Sigma-Aldrich
Hydrochloric acid solution, 0.05 M
Sigma-Aldrich
Hydrogen chloride – ethanol solution, 0.1 M in ethanol
Sigma-Aldrich
Hydrochloric acid solution, 12 M
Sigma-Aldrich
Acetic acid-12C2, 99.9 atom % 12C
Sigma-Aldrich
Sodium sulfate, JIS special grade, ≥99.0%
Sigma-Aldrich
di-Sodium hydrogen phosphate dihydrate, BioXtra, ≥98.0% (T)
Sigma-Aldrich
di-Sodium hydrogen phosphate dihydrate, BioUltra, Molecular Biology, ≥99.0% (T)
Sigma-Aldrich
Acetic acid, suitable for luminescence, BioUltra, ≥99.5% (GC)
Supelco
Acetic acid, analytical standard
Supelco
Hydrogen chloride – 2-propanol solution, ~1.25 M HCl (T), derivatization grade (GC derivatization), LiChropur
Supelco
Ibuprofen, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Dehydrated Alcohol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
di-Sodium hydrogen phosphate dihydrate, tested according to Ph. Eur.
Supelco
Ethanol solution, certified reference material, 2000 μg/mL in methanol